Loading clinical trials...
Loading clinical trials...
Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery-focused on Beta Cell Function and Insulin Sensitivity Changes
Conditions
Interventions
Laparoscopic Sleeve Gastrectomy
Start Date
April 1, 2012
Primary Completion Date
June 1, 2022
Completion Date
December 1, 2024
Last Updated
April 6, 2022
NCT05783466
NCT02937649
NCT06268990
NCT04564391
NCT03851627
NCT03156478
Lead Sponsor
Dasman Diabetes Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions